Jointly, UMHS and Allegiance Wellness will build on our non-profit legacies of quality treatment to provide even greater value to patients and sustainable wellness improvement for all, including underserved populations, said Georgia Fojtasek, R.N., Ed.D., president and CEO of Allegiance Wellness. In UMHS, Allegiance Health has found somebody that shares our eyesight and commitment. By joining one of the state's premier healthcare systems, Allegiance Health is building on our long-standing commitment to become a more effective and efficient organization, resulting in even top quality and cost-effective health care for our community. Ora Hirsch Pescovitz, M.D., CEO of UMHS and executive vice president for medical affairs at U-M, believes the proposed romantic relationship between Allegiance Health and UMHS can help patients receive treatment in the positioning best for them, which is near home often.We have become pleased by these results, which we intend to post to the FDA to help expand support the use of AVYCAZ as cure option for patients with these significant and life-threatening complicated urinary tract attacks, stated David Nicholson, Executive Vice President & President, Global Brands R&D at Allergan. AstraZeneca is committed to addressing the general public health challenge posed by emerging infections through our portfolio of innovative antibiotics. Allergan plans to submit this data as a supplemental New Drug Application to the meals and Medication Administration by the finish of 2015. Ceftazidime-avibactam is being jointly developed with AstraZeneca. Allergan holds the privileges to commercialize ceftazidime-avibactam in North America, while AstraZeneca keeps the rights to commercialize ceftazidime-avibactam in all of those other global world.
3-month grace period for NYC’s big soda ban NEW YORKNew York City’s ban on big sodas is defined to go into effect in March, but businesses will even now have a couple of months to adjust to the brand new regulations before they’re hit with fines.